Aatmaj HealthQ2 FY24

Aatmaj Health Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 18.6P/E: 58.4Market Cap: ₹42 CrSector: Healthcare Services

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

No information is provided regarding the same in the latest conference call.

See what Aatmaj Health management said on margin guidance — free account, 30 seconds.

Fundraise plans

No information is provided regarding the same in the latest conference call.

See what Aatmaj Health management said on order book — free account, 30 seconds.

Capex plans

No information is provided regarding the same in the latest conference call.

Track Aatmaj Health — get its next earnings analysis in your feed

Margin guidance

No information is provided regarding the same in the latest conference call.

Order book

No information is provided regarding the same in the latest conference call.

How does Aatmaj Health rank vs peers in Healthcare Services?

Pro feature
1Aatmaj Health

See full Healthcare Services sector rankings

How does Aatmaj Health rank in Healthcare Services?

Compare Aatmaj Health against every Healthcare Services company (Q2 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

What Aatmaj Health's management said in earlier quarters

Others in Healthcare Services this season

  • Metropolis Healt (Q1 FY27)

    East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…

  • Apollo Hospitals (Q1 FY27)

    IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

  • Health X Platform (Q1 FY27)

    July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…

  • Shalby (Q1 FY27)

    Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →